Flora Growth Corp (NASDAQ:FLGC) (FSE:7301) reported its financial and operating results Monday for the second quarter ended June 30. The Florida-based cannabis company disclosed revenue of $15.68 million, down from $21.46 million in the same period last year. As per the regulatory filing, the company attributed the revenue decline to JustCBD's performance in the quarter, which had $4.4 million in sales. In the same period of 2023, JustCBD had $9.0 million in sales. This performance was caused by the company's 2023 decision to discontinue several unprofitable product lines as well as growing competition and market saturation. The earnings report comes shortly after company listed on the Frankfurt Stock Exchange, with the goal of connecting with European investors. “In the second quarter of 2024, we at Flora, demonstrated an aptitude to make accretive acquisitions and form strategic partnerships to capitalize on the most robust market trends," ...